Bio-Path Holdings, Inc. (BPTH)
NASDAQ: BPTH · Real-Time Price · USD
1.220
-0.130 (-9.63%)
Dec 27, 2024, 1:03 PM EST - Market open
Bio-Path Holdings Stock Forecast
BPTH's stock price has decreased by -87.56% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Bio-Path Holdings stock have an average target of 30, with a low estimate of 20 and a high estimate of 40. The average target predicts an increase of 2,359.02% from the current stock price of 1.22.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 8, 2024.
Analyst Ratings
The average analyst rating for BPTH stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Roth MKM | Roth MKM | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +1,539.34% | Jul 8, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +3,178.69% | Apr 18, 2024 |
Roth MKM | Roth MKM | Strong Buy Maintains $12 → $40 | Strong Buy | Maintains | $12 → $40 | +3,178.69% | Mar 27, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $240 → $180 | Strong Buy | Maintains | $240 → $180 | +14,654.10% | May 19, 2022 |
Roth Capital | Roth Capital | Strong Buy Initiates $260 | Strong Buy | Initiates | $260 | +21,211.48% | Mar 11, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.23
from -33.64
EPS Next Year
-1.58
from -3.23
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | n/a | |||
Avg | n/a | n/a | n/a | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -3.33 | -1.63 | -1.55 | |||
Avg | -3.23 | -1.58 | -1.51 | |||
Low | -3.11 | -1.52 | -1.45 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.